메뉴 건너뛰기




Volumn 193, Issue 1, 2015, Pages 80-86

Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries

Author keywords

hypogonadism; incidence; prostatic neoplasms; testosterone; testosterone undecanoate

Indexed keywords

TESTOSTERONE UNDECANOATE; ANDROGEN; TESTOSTERONE;

EID: 85028161077     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.06.071     Document Type: Article
Times cited : (78)

References (30)
  • 1
    • 84878704250 scopus 로고    scopus 로고
    • Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes
    • Hackett, G., Cole, N., Bhartia, M., et al. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med, 10, 2013, 1612.
    • (2013) J Sex Med , vol.10 , pp. 1612
    • Hackett, G.1    Cole, N.2    Bhartia, M.3
  • 2
    • 84885371224 scopus 로고    scopus 로고
    • Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss
    • Saad, F., Haider, A., Doros, G., et al. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity, 21, 2013, 1975.
    • (2013) Obesity , vol.21 , pp. 1975
    • Saad, F.1    Haider, A.2    Doros, G.3
  • 3
    • 84896689377 scopus 로고    scopus 로고
    • Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
    • Traish, A.M., Haider, A., Doros, G., et al. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract, 68, 2014, 314.
    • (2014) Int J Clin Pract , vol.68 , pp. 314
    • Traish, A.M.1    Haider, A.2    Doros, G.3
  • 4
    • 84897814576 scopus 로고    scopus 로고
    • Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome
    • Article ID 527470
    • Francomano, D., Lenzi, A., Aversa, A., Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome. Int J Endocrinol, 2014 Article ID 527470.
    • (2014) Int J Endocrinol
    • Francomano, D.1    Lenzi, A.2    Aversa, A.3
  • 5
    • 84856939978 scopus 로고    scopus 로고
    • Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010
    • Gooren, L.J., Behre, H.M., Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010. Aging Male, 15, 2012, 22.
    • (2012) Aging Male , vol.15 , pp. 22
    • Gooren, L.J.1    Behre, H.M.2
  • 6
    • 57649176913 scopus 로고    scopus 로고
    • Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth
    • Morgentaler, A., Traish, A.M., Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol, 55, 2009, 310.
    • (2009) Eur Urol , vol.55 , pp. 310
    • Morgentaler, A.1    Traish, A.M.2
  • 7
    • 57749088367 scopus 로고    scopus 로고
    • Testosterone and the prostate: implications for the treatment of hypogonadal men
    • Holyoak, J.D., Crawford, E.D., Meacham, R.B., Testosterone and the prostate: implications for the treatment of hypogonadal men. Curr Urol Rep, 9, 2008, 500.
    • (2008) Curr Urol Rep , vol.9 , pp. 500
    • Holyoak, J.D.1    Crawford, E.D.2    Meacham, R.B.3
  • 9
    • 84867052045 scopus 로고    scopus 로고
    • Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial
    • Muller, R.L., Gerber, L., Moreira, D.M., et al. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial. Eur Urol, 62, 2012, 757.
    • (2012) Eur Urol , vol.62 , pp. 757
    • Muller, R.L.1    Gerber, L.2    Moreira, D.M.3
  • 10
    • 39149084101 scopus 로고    scopus 로고
    • Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies
    • Roddam, A.W., Allen, N.E., Appleby, P., et al. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst, 100, 2008, 170.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 170
    • Roddam, A.W.1    Allen, N.E.2    Appleby, P.3
  • 11
    • 84888840943 scopus 로고    scopus 로고
    • A new era of testosterone and prostate cancer: from physiology to clinical implications
    • Khera, M., Crawford, D., Morales, A., et al. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol, 65, 2014, 115.
    • (2014) Eur Urol , vol.65 , pp. 115
    • Khera, M.1    Crawford, D.2    Morales, A.3
  • 12
    • 84880036090 scopus 로고    scopus 로고
    • Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy
    • Pastuszak, A.W., Pearlman, A.M., Lai, W.S., et al. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol, 190, 2013, 639.
    • (2013) J Urol , vol.190 , pp. 639
    • Pastuszak, A.W.1    Pearlman, A.M.2    Lai, W.S.3
  • 13
    • 33645794792 scopus 로고    scopus 로고
    • EAU guidelines on erectile dysfunction: an update
    • Wespes, E., Amar, E., Hatzichristou, D., et al. EAU guidelines on erectile dysfunction: an update. Eur Urol, 49, 2006, 806.
    • (2006) Eur Urol , vol.49 , pp. 806
    • Wespes, E.1    Amar, E.2    Hatzichristou, D.3
  • 14
    • 84888815889 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013
    • Heidenreich, A., Bastian, P.J., Bellmunt, J., et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol, 65, 2014, 124.
    • (2014) Eur Urol , vol.65 , pp. 124
    • Heidenreich, A.1    Bastian, P.J.2    Bellmunt, J.3
  • 15
    • 63249122661 scopus 로고    scopus 로고
    • Mortality results from a randomized prostate-cancer screening trial
    • Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360, 2009, 1310.
    • (2009) N Engl J Med , vol.360 , pp. 1310
    • Andriole, G.L.1    Crawford, E.D.2    Grubb, R.L.3
  • 16
    • 84858212484 scopus 로고    scopus 로고
    • Prostate-cancer mortality at 11 years of follow-up
    • Schröder, F.H., Hugosson, J., Roobol, M.J., et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med, 366, 2012, 981.
    • (2012) N Engl J Med , vol.366 , pp. 981
    • Schröder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 17
    • 84880923151 scopus 로고    scopus 로고
    • Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes
    • Kaplan, A.L., Hu, J.C., Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Urology, 82, 2013, 321.
    • (2013) Urology , vol.82 , pp. 321
    • Kaplan, A.L.1    Hu, J.C.2
  • 18
    • 2442543161 scopus 로고    scopus 로고
    • Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
    • Wang, C., Cunningham, G., Dobs, A., et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab, 89, 2004, 2085.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2085
    • Wang, C.1    Cunningham, G.2    Dobs, A.3
  • 19
    • 58149512149 scopus 로고    scopus 로고
    • Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review
    • Shabsigh, R., Crawford, E.D., Nehra, A., et al. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res, 21, 2009, 9.
    • (2009) Int J Impot Res , vol.21 , pp. 9
    • Shabsigh, R.1    Crawford, E.D.2    Nehra, A.3
  • 20
    • 77954394453 scopus 로고    scopus 로고
    • Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis
    • Fernández-Balsells, M.M., Murad, M.H., Lane, M., et al. Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab, 95, 2010, 2560.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 2560
    • Fernández-Balsells, M.M.1    Murad, M.H.2    Lane, M.3
  • 21
    • 84885423616 scopus 로고    scopus 로고
    • The effect of androgen-replacement therapy on prostate growth: a systematic review and meta-analysis
    • Cui, Y., Zhang, Y., The effect of androgen-replacement therapy on prostate growth: a systematic review and meta-analysis. Eur Urol, 64, 2013, 811.
    • (2013) Eur Urol , vol.64 , pp. 811
    • Cui, Y.1    Zhang, Y.2
  • 22
    • 85033679667 scopus 로고    scopus 로고
    • Guidelines on male hypogonadism. Available at Accessed February 2012.
    • Dohle GR, Arver S, Bettocchi C et al: Guidelines on male hypogonadism. Available at www.uroweb.org/gls/pdf/16_Male_Hypogonadism_LR%20II.pdf. Accessed February 2012.
    • Dohle, G.R.1    Arver, S.2    Bettocchi, C.3
  • 23
    • 56249088599 scopus 로고    scopus 로고
    • Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations
    • Wang, C., Nieschlag, E., Swerdloff, R., et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol, 55, 2009, 121.
    • (2009) Eur Urol , vol.55 , pp. 121
    • Wang, C.1    Nieschlag, E.2    Swerdloff, R.3
  • 24
    • 84872852291 scopus 로고    scopus 로고
    • Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment
    • Buvat, J., Maggi, M., Guay, A., et al. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med, 10, 2013, 245.
    • (2013) J Sex Med , vol.10 , pp. 245
    • Buvat, J.1    Maggi, M.2    Guay, A.3
  • 25
    • 77954409942 scopus 로고    scopus 로고
    • Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
    • Bhasin, S., Cunningham, G.R., Hayes, F.J., et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 95, 2010, 2536.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 2536
    • Bhasin, S.1    Cunningham, G.R.2    Hayes, F.J.3
  • 26
    • 67349282280 scopus 로고    scopus 로고
    • Testosterone and prostate cancer: revisiting old paradigms
    • Isbarn, H., Pinthus, J.H., Marks, L.S., et al. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol, 56, 2009, 48.
    • (2009) Eur Urol , vol.56 , pp. 48
    • Isbarn, H.1    Pinthus, J.H.2    Marks, L.S.3
  • 27
    • 80051923470 scopus 로고    scopus 로고
    • Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer
    • Morgentaler, A., Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer. Cancer, 117, 2011, 3885.
    • (2011) Cancer , vol.117 , pp. 3885
    • Morgentaler, A.1
  • 28
    • 79952698470 scopus 로고    scopus 로고
    • Testosterone therapy in men with untreated prostate cancer
    • Morgentaler, A., Lipshultz, L.I., Bennett, R., et al. Testosterone therapy in men with untreated prostate cancer. J Urol, 185, 2011, 1256.
    • (2011) J Urol , vol.185 , pp. 1256
    • Morgentaler, A.1    Lipshultz, L.I.2    Bennett, R.3
  • 29
    • 84876422426 scopus 로고    scopus 로고
    • Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment
    • Morgentaler, A., Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment. BJU Int, 110, 2012, E547.
    • (2012) BJU Int , vol.110 , pp. E547
    • Morgentaler, A.1
  • 30
    • 67349251251 scopus 로고    scopus 로고
    • Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth
    • Rinnab, L., Gust, K., Hautmann, R.E., et al. Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth. Urologe A, 48, 2009, 516.
    • (2009) Urologe A , vol.48 , pp. 516
    • Rinnab, L.1    Gust, K.2    Hautmann, R.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.